Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Lysosomal recruitment of TSC2 is a universal response to cellular stress

View through CrossRef
AbstractmTORC1 promotes cell growth and is therefore inactivated upon unfavourable growth conditions. Signalling pathways downstream of most cellular stresses converge on TSC1/2, which serves as an integration point that inhibits mTORC1. The TSC1/2 complex was shown to translocate to lysosomes to inactivate mTORC1 in response to two stresses: amino-acid starvation and growth factor removal. Whether other stresses also regulate TSC2 localization is not known. How TSC2 localization responds to combinations of stresses and other stimuli is also unknown. We show that both amino acids and growth factors are required simultaneously to maintain TSC2 cytoplasmic; when one of the two is missing, TSC2 relocalizes to lysosomes. Furthermore, multiple different stresses that inhibit mTORC1 also drive TSC2 lysosomal accumulation. Our findings indicate that lysosomal recruitment of TSC2 is a universal response to stimuli that inactivate mTORC1, and that the presence of any single stress is sufficient to cause TSC2 lysosomal localization.
Title: Lysosomal recruitment of TSC2 is a universal response to cellular stress
Description:
AbstractmTORC1 promotes cell growth and is therefore inactivated upon unfavourable growth conditions.
Signalling pathways downstream of most cellular stresses converge on TSC1/2, which serves as an integration point that inhibits mTORC1.
The TSC1/2 complex was shown to translocate to lysosomes to inactivate mTORC1 in response to two stresses: amino-acid starvation and growth factor removal.
Whether other stresses also regulate TSC2 localization is not known.
How TSC2 localization responds to combinations of stresses and other stimuli is also unknown.
We show that both amino acids and growth factors are required simultaneously to maintain TSC2 cytoplasmic; when one of the two is missing, TSC2 relocalizes to lysosomes.
Furthermore, multiple different stresses that inhibit mTORC1 also drive TSC2 lysosomal accumulation.
Our findings indicate that lysosomal recruitment of TSC2 is a universal response to stimuli that inactivate mTORC1, and that the presence of any single stress is sufficient to cause TSC2 lysosomal localization.

Related Results

Abstract A01: Vps34 promotes macropinocytosis in Tsc2-deficient cells
Abstract A01: Vps34 promotes macropinocytosis in Tsc2-deficient cells
Abstract Purpose: The mechanistic/mammalian target of rapamycin complex 1 (mTORC1) is constitutively active in many human cancers and in tuberous sclerosis complex (...
Abstract 1721: FOXO1, a downstream substrate of AKT, function as tumor suppressor in HCC carcinogenesis
Abstract 1721: FOXO1, a downstream substrate of AKT, function as tumor suppressor in HCC carcinogenesis
Abstract Hepatocellular carcinoma (HCC) represents the fifth most common tumor types in the world and the third leading cause of cancer-related death. However, the s...
SISTEM REKRUITMEN DAN KADERISASI PARTAI KEADILAN SEJAHTERA DI JAWA BARAT
SISTEM REKRUITMEN DAN KADERISASI PARTAI KEADILAN SEJAHTERA DI JAWA BARAT
This research entitled �the system of Recruitmen and the prosperous justice party cadre recruitment in West Java�. The real problem in this research not yet optimal recruitment and...
Src Kinase Is a Novel Therapeutic Target in Lymphangioleiomyomatosis
Src Kinase Is a Novel Therapeutic Target in Lymphangioleiomyomatosis
Abstract Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease affecting some women with tuberous sclerosis complex (TSC). Sporadic LAM can develop in ...
Data from Src Kinase Is a Novel Therapeutic Target in Lymphangioleiomyomatosis
Data from Src Kinase Is a Novel Therapeutic Target in Lymphangioleiomyomatosis
<div>Abstract<p>Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease affecting some women with tuberous sclerosis complex (TSC). Sporadic LAM can develop...
Data from Src Kinase Is a Novel Therapeutic Target in Lymphangioleiomyomatosis
Data from Src Kinase Is a Novel Therapeutic Target in Lymphangioleiomyomatosis
<div>Abstract<p>Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease affecting some women with tuberous sclerosis complex (TSC). Sporadic LAM can develop...

Back to Top